Miranda GB, Morales CM

Language: Spanish
References: 18
Page: 55-59
PDF size: 725.87 Kb.

ABSTRACT

Castleman’s disease is an atypical lymphoproliferative entity. It is characterized by a lymph node angiofollicular hyperplasia. It can be presented as a localized or multicentric disease. The incidence of cervical cases reported in literature until now is 6%. A case of disease of Castleman of cervical location is reported, as well as revision of Literature about the clinical presentation, the histological characteristics and the handling in different series of studied patients and the previous experience in the Hispanic Hospital of Mexico City.

REFERENCES

1. 1.-Castleman B, Iverson L, Menéndez VP. “Localized mediastinal lymph-node hyperplasia resembling thymoma”. Cancer. 1956;9:822-30.

2. 2.-Kazes I, Deray G, Jacobs C. “Castleman Disease and Renal amyloidosis”. Ann. Intern. Med. 1995;122(5):395-396.

3. 3.-Shahidi H, Myers J, Kvale P. “Castleman’s disease (subject review”). Mayo Clin. Proc. 1995;70:969-977.

4. 4.-Herrada J, Cabanillas F, Rice L, Manning J, Pugh W. “The clinical Behavior of Localized and Multicentric Castleman Disease”. Ann. Intern. Med. 1998;128:657-662.

5. 5.-Marti S, Pahissa A, Guardia J, Moragas A, Bacardi R. “Multicentric Giant Follicular Lymph Node Hyperplasia. Favorable response to radiotherapy”. Cancer. 1983;51:808-810.

6. 6.-Habermann T, Steensma D. “Lymphadenopathy”. Mayo Clin. Proc. 2000;75(7):723-732. 7.-Scully RE, Mark EJ, McNeely WF, McNeely BU. “Case records of the Massachussets General Hospital Case 39-1992”. N. Engl. J. Med. 1992;327:1014-21.

7. 8.-Scully RE, Mark EJ, McNeely WF, McNeely BU. “Case records of the Massachussets General Hospital Case 39-1990”. N. Engl. J. Med. 1990;323:895-908.

8. 9.-Feigert JM, Sweet DL, Coleman M, Variakojis D, Wisch N, Schulman J, et al. “Multicentric angiofollicular lymph node hyperplasia with peripheral neuropathy, pseudomotor cerebri, IgA disproteinemia, and thrombocitosis in women”. Ann. Intern. Med. 1990;113:362-367.

9. 10.-Kessler E. “Multicentric giant limph node hyperplasia. A report of seven cases”. Cancer.1985;56:2446-2451.

10. 11.-Pérez Astorga R, Zárate Osorno A, Sánchez Marle JF. “Hiperplasia ganglionar angiofolicular de Castleman. Reporte de un caso de localización cervical”. Anales Soc. Méx. Otorrinolar. 1985;34:46-50.

11. 12.-Zietz C, Bogner JR, Goebel FD, Lohrs U. “An unusual cluster of cases of Castleman’s disease during highly active antiretroviral therapy for AIDS”. N. Engl. J. Med.1999;340 1923-1924.

12. 13.-Ahmed R, Adhami NA, Hanif M, Ayinla R, Rahman H, Fleischman J. “Unicentric Castleman Disease: a case report and review of literature”. Chest.1999;116supp.2:410S

13. 14.-Hsu S, Waldron JA, Xie S, Barlogie B. “Expression of interleukin-6 in Castleman’s disease”. Hum. Pathol. 1993;24:833-839.

14. 15.-Leger-Ravet MB, Peuchmaur M, Devergne O, Audouin J, Raphael M, Van Damme J, et al. “Interleukin-6 gene expression in Castleman’s disease”. Blood, 1991 ;78 :2923-2930.

15. 16.-Prado Calleros H, Guzmán Urrutia R, Arrieta Gómez JR, Bross Sorian D, García García MA, Recinos Carrera HG. “Enfermedad de Castleman de presentación cervical reporte de un caso”. Rev. ORL. Mex.1999;44:191-194.

16. 17.-Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, et al. “Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease”. Blood.1995;86:1276-1280.

17. 18.-Chim Chor S, Lam King Y, Chan Kwok W. “Castleman’s disease with Kaposi’s sarcoma and glomerulonephritis”. Am. J. Med.1999;107:186-188.

18. 19.-Beck JT, Hsu Su-Ming, Wijdenes J, Bataille R, Klein B, Vesole D, et al. “Brief report : alleviation of systemic manifestations of Castleman’s disease by monoclonal anti-interleukin-6 antibody”. New Eng. J. Med.1994;330:602-605.